Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes.
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The main objective of this clinical research trial is to test the efficacy of OXO-001 in a
daily oral administration increasing the pregnancy rate in IVF/ICSI by preparing the uterus
to receive the embryo.